Evidence map›Paper›PMID 42261202›Full record

ReviewInternational journal of cancer2026

The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change.

James D Brierley, Liesbet J Van Eycken, Meredith E Giuliani, Brian A Rous, Shao Hui Huang, Hisao Asamura, Mary K Gospodarowicz, Anne W Lee, Brian O'Sullivan

Abstract readReview
In one paragraph

Review in International journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. CancerWatch: accelerating Europe's cancer intelligence.Acta oncologica (Stockholm, Sweden) · 2026
    Article
  2. Article
  3. Article
  4. Union for International Cancer Control 9Turkish archives of otorhinolaryngology · 2025
    Article
  5. Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

James D BrierleyDepartment of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Liesbet J Van EyckenBelgian Cancer Registry, Brussels, Belgium.ORCID https://orcid.org/0000-0003-4788-968X
Meredith E GiulianiDepartment of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Brian A RousCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Shao Hui HuangDepartment of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Hisao AsamuraKeio University School of Medicine, Tokyo, Japan.
Mary K GospodarowiczDepartment of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Anne W LeeDepartment of Clinical Oncology, University of Hong Kong, Hong Kong, Hong Kong.
Brian O'SullivanDepartment of Radiology, Radiation Oncology and Nuclear Medicine, Centre Hospitalier de l'Universite de Montreal, University of Montreal, Montreal, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s. Due to the expanding medical knowledge of tumour behaviour and advances in imaging, pathology and therapeutic options, TNM has been updated in collaboration with the American Joint Committee on Cancer (AJCC), the International Association for the study of Lung Cancer (IASLC) and the Federation Internationale de Gynecologie et d'Obstetrique (FIGO) on a regular basis. The 9th edition of the UICC TNM Classification of Malignant Tumours has recently been published. This review summarized the changes between the 8th and 9th edition. The evidence basis used for revision is described and referenced, with a focus on the changes in head and neck and lung cancers.

Indexed as

Lung NeoplasmsNeoplasmsNeoplasm StagingHumansLymphatic Metastasiscancer stageevidence based revisionTNM

Identifiers

PMID42261202
PMCPMC13432304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.